These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15588066)
1. Pathophysiology of antiphospholipid antibodies. de Groot PG; Derksen RH Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066 [TBL] [Abstract][Full Text] [Related]
2. Beta2-glycoprotein I and LDL-receptor family members. de Groot PG; van Lummel M; Pennings M; Urbanus R; Bas de Laat H; Lenting PJ; Derksen RH Thromb Res; 2004; 114(5-6):455-9. PubMed ID: 15507278 [TBL] [Abstract][Full Text] [Related]
3. The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome. de Groot PG; Derksen RH; Urbanus RT Lupus; 2010 Apr; 19(4):389-93. PubMed ID: 20353975 [TBL] [Abstract][Full Text] [Related]
5. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Bas de Laat H; Derksen RH; de Groot PG Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159 [TBL] [Abstract][Full Text] [Related]
6. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Urbanus RT; Derksen RH; de Groot PG Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017 [TBL] [Abstract][Full Text] [Related]
7. Recent developments in our understanding of the antiphospholipid syndrome. De Groot PG; Meijers JC; Urbanus RT Int J Lab Hematol; 2012 Jun; 34(3):223-31. PubMed ID: 22394675 [TBL] [Abstract][Full Text] [Related]
8. Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states. Chen PP; Wu M; Hahn BH Lupus; 2010 Apr; 19(4):365-9. PubMed ID: 20353971 [TBL] [Abstract][Full Text] [Related]
9. Increased plasma thrombomodulin in different subgroups of patients with antiphospholipid and anti beta(2) glycoprotein I antibodies. Martinuzzo ME; Forastiero RR; Carreras LO Thromb Haemost; 1996 Jun; 75(6):972-3. PubMed ID: 8822596 [No Abstract] [Full Text] [Related]
10. "Resurrection of thrombin" in the pathophysiology of the antiphospholipid syndrome. Koike T; Atsumi T Arthritis Rheum; 2007 Feb; 56(2):393-4. PubMed ID: 17265473 [No Abstract] [Full Text] [Related]
12. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W; Matthias T; Scharrer I Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies: specificity and pathophysiology. de Groot PG; Oosting JD; Derksen RH Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348 [TBL] [Abstract][Full Text] [Related]
18. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome. Lutters BC; de Groot PG; Derksen RH Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190 [No Abstract] [Full Text] [Related]
19. The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? Ortel TL J Thromb Thrombolysis; 2006 Feb; 21(1):79-83. PubMed ID: 16475047 [TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis in the antiphospholipid syndrome. Farmer-Boatwright MK; Roubey RA Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]